Cargando…

JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure

Bcl-2 E1B 19-KDa interacting protein 3 (BNIP3) is a mitochondrial death and mitophagy marker, which is involved in inducing cardiac remodeling post myocardial infarction. In this study, we show that BNIP3 expression increases in stressed cardiomyocytes in vitro and in response to pressure overload i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaanine, A H, Jeong, D, Liang, L, Chemaly, E R, Fish, K, Gordon, R E, Hajjar, R J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288347/
https://www.ncbi.nlm.nih.gov/pubmed/22297293
http://dx.doi.org/10.1038/cddis.2012.5
_version_ 1782224812760891392
author Chaanine, A H
Jeong, D
Liang, L
Chemaly, E R
Fish, K
Gordon, R E
Hajjar, R J
author_facet Chaanine, A H
Jeong, D
Liang, L
Chemaly, E R
Fish, K
Gordon, R E
Hajjar, R J
author_sort Chaanine, A H
collection PubMed
description Bcl-2 E1B 19-KDa interacting protein 3 (BNIP3) is a mitochondrial death and mitophagy marker, which is involved in inducing cardiac remodeling post myocardial infarction. In this study, we show that BNIP3 expression increases in stressed cardiomyocytes in vitro and in response to pressure overload in vivo, and that its transcription is directly related to JNK activity. BNIP3 expression gradually increased in the first weeks after pressure overload and peaked at the heart failure stage. Ultrastructurally, the mitochondrial area was inversely proportional to BNIP3 expression. Both JNK and AKT activities increased with pressure overload; however, JNK signaling dominated over AKT signaling for the activation of the transcription factor FOXO3a and for the transcription of its effector, BNIP3. 3-methyladenine attenuated JNK signaling and significantly decreased BNIP3 expression and reversed cardiac remodeling in heart failure. Ultrastructurally, the mitochondrial area was significantly increased in the 3-methyladenine group compared with placebo. Moreover, adenoviral gene delivery of dominant negative JNK in a rat model of pressure overload hypertrophy abolished the increase in BNIP3 expression in response to pressure overload. These results suggest that JNK signaling is a critical modulator of the transcription factor FOXO3a driving the expression of its effector, BNIP3, in heart failure and that JNK, through BNIP3, induces mitochondrial apoptosis and mitophagy.
format Online
Article
Text
id pubmed-3288347
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-32883472012-02-28 JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure Chaanine, A H Jeong, D Liang, L Chemaly, E R Fish, K Gordon, R E Hajjar, R J Cell Death Dis Original Article Bcl-2 E1B 19-KDa interacting protein 3 (BNIP3) is a mitochondrial death and mitophagy marker, which is involved in inducing cardiac remodeling post myocardial infarction. In this study, we show that BNIP3 expression increases in stressed cardiomyocytes in vitro and in response to pressure overload in vivo, and that its transcription is directly related to JNK activity. BNIP3 expression gradually increased in the first weeks after pressure overload and peaked at the heart failure stage. Ultrastructurally, the mitochondrial area was inversely proportional to BNIP3 expression. Both JNK and AKT activities increased with pressure overload; however, JNK signaling dominated over AKT signaling for the activation of the transcription factor FOXO3a and for the transcription of its effector, BNIP3. 3-methyladenine attenuated JNK signaling and significantly decreased BNIP3 expression and reversed cardiac remodeling in heart failure. Ultrastructurally, the mitochondrial area was significantly increased in the 3-methyladenine group compared with placebo. Moreover, adenoviral gene delivery of dominant negative JNK in a rat model of pressure overload hypertrophy abolished the increase in BNIP3 expression in response to pressure overload. These results suggest that JNK signaling is a critical modulator of the transcription factor FOXO3a driving the expression of its effector, BNIP3, in heart failure and that JNK, through BNIP3, induces mitochondrial apoptosis and mitophagy. Nature Publishing Group 2012-02 2012-02-02 /pmc/articles/PMC3288347/ /pubmed/22297293 http://dx.doi.org/10.1038/cddis.2012.5 Text en Copyright © 2012 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Chaanine, A H
Jeong, D
Liang, L
Chemaly, E R
Fish, K
Gordon, R E
Hajjar, R J
JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure
title JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure
title_full JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure
title_fullStr JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure
title_full_unstemmed JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure
title_short JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure
title_sort jnk modulates foxo3a for the expression of the mitochondrial death and mitophagy marker bnip3 in pathological hypertrophy and in heart failure
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288347/
https://www.ncbi.nlm.nih.gov/pubmed/22297293
http://dx.doi.org/10.1038/cddis.2012.5
work_keys_str_mv AT chaanineah jnkmodulatesfoxo3afortheexpressionofthemitochondrialdeathandmitophagymarkerbnip3inpathologicalhypertrophyandinheartfailure
AT jeongd jnkmodulatesfoxo3afortheexpressionofthemitochondrialdeathandmitophagymarkerbnip3inpathologicalhypertrophyandinheartfailure
AT liangl jnkmodulatesfoxo3afortheexpressionofthemitochondrialdeathandmitophagymarkerbnip3inpathologicalhypertrophyandinheartfailure
AT chemalyer jnkmodulatesfoxo3afortheexpressionofthemitochondrialdeathandmitophagymarkerbnip3inpathologicalhypertrophyandinheartfailure
AT fishk jnkmodulatesfoxo3afortheexpressionofthemitochondrialdeathandmitophagymarkerbnip3inpathologicalhypertrophyandinheartfailure
AT gordonre jnkmodulatesfoxo3afortheexpressionofthemitochondrialdeathandmitophagymarkerbnip3inpathologicalhypertrophyandinheartfailure
AT hajjarrj jnkmodulatesfoxo3afortheexpressionofthemitochondrialdeathandmitophagymarkerbnip3inpathologicalhypertrophyandinheartfailure